
Happiness Biotech Group Limited HAPP
Happiness Biotech Group Limited DIO Ratio | HAPP
Annual DIO Ratio Happiness Biotech Group Limited
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.6 | 1.91 K | - | - | 28.3 | 13.1 | 21.1 | 11.3 | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.91 K | 11.3 | 332 |
Quarterly DIO Ratio Happiness Biotech Group Limited
| 2026-Q4 | 2026-Q2 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 2.73 | 504 | 477 | - | - | - | 2.54 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 504 | 2.54 | 246 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
KalVista Pharmaceuticals
KALV
|
203 | - | - | $ 1.45 B | ||
|
KemPharm
KMPH
|
41.1 | - | -0.34 % | $ 200 M | ||
|
NovaBay Pharmaceuticals
NBY
|
70 | - | - | $ 11.3 M | ||
|
OncoCyte Corporation
OCX
|
89.3 | - | 17.22 % | $ 355 K | ||
|
Plus Therapeutics
PSTV
|
937 | - | - | $ 301 M | ||
|
Qualigen Therapeutics
QLGN
|
60.6 | - | 5.59 % | $ 1.16 M | ||
|
Qilian International Holding Group Limited
QLI
|
145 | - | -6.08 % | $ 184 M | ||
|
Salarius Pharmaceuticals
SLRX
|
158 | - | - | $ 2.64 M | ||
|
Sonnet BioTherapeutics Holdings
SONN
|
4.35 | - | - | $ 826 K | ||
|
Windtree Therapeutics
WINT
|
70.2 | - | - | $ 26.8 M | ||
|
Palatin Technologies
PTN
|
983 | - | - | $ 13 M | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Завод ДИОД
DIOD
|
768 | - | - | - | ||
|
Фармсинтез
LIFE
|
120 | - | - | - |